Moneycontrol PRO
you are here: HomeNewsModerna
moderna
Jump to
  • U.S. FDA advisers back COVID vaccines for children as young as 6 months Jun 17, 2022 06:44 PM IST

    U.S. FDA advisers back COVID vaccines for children as young as 6 months

    On Wednesday, a panel of FDA advisers unanimously recommended that the agency approve COVID-19 vaccinations from Moderna Inc and Pfizer Inc/BioNTech SE for millions of youngsters in the United States.

  • Moderna COVID vaccine may pose higher heart inflammation risk - U.S. CDC Jun 14, 2022 06:46 PM IST

    Moderna COVID vaccine may pose higher heart inflammation risk - U.S. CDC

    The US Centers for Disease Control and Prevention stated on Tuesday that Moderna's (MRNA.O) COVID-19 vaccine may cause more cardiac inflammation in some age groups than Pfizer-(PFE.N) BioNTech's injection, citing recent research.

  • Moderna says Omicron-specific booster generates strong immune response Jun 08, 2022 05:19 PM IST

    Moderna says Omicron-specific booster generates strong immune response

    Moderna Inc said on Wednesday that its COVID-19 vaccine booster, which targets both the original coronavirus strain and Omicron, elicited a stronger immune response against the variant than the company's previous vaccine.

  • Japan study shows women more likely to get skin rash from Moderna shot Jun 02, 2022 08:01 AM IST

    Japan study shows women more likely to get skin rash from Moderna shot

    The study of 5,893 participants between May and November last year showed that 22.4% of women developed delayed skin reactions after the first shot, compared to 5.1% of men.

  • Moderna CEO Bancel says he’ll give most of his money away May 26, 2022 10:00 PM IST

    Moderna CEO Bancel says he’ll give most of his money away

    Moderna Inc. Chief Executive Officer Stephane Bancel said he plans to donate the bulk of his family wealth, focusing his philanthropy on issues such as health care and ghobal food security.

  • India right example for ensuring vaccine equity, stepping up manufacturing: Leaders at World Economic Forum May 23, 2022 07:05 PM IST

    India right example for ensuring vaccine equity, stepping up manufacturing: Leaders at World Economic Forum

    Leaders at the World Economic Forum on Monday said everyone else needs to follow the Indian model to ensure vaccine equity and wider inoculation.

  • Fourth COVID-19 vaccine dose provides strong immunity boost: UK study May 11, 2022 03:25 PM IST

    Fourth COVID-19 vaccine dose provides strong immunity boost: UK study

    The findings, published in The Lancet Infectious Disease journal, show that fourth dose mRNA booster vaccines for COVID-19 are well-tolerated in people who received Pfizer as a third dose.

  • Moderna Q1 profit triples as COVID vaccine sales beat expectations May 04, 2022 08:03 PM IST

    Moderna Q1 profit triples as COVID vaccine sales beat expectations

    Moderna, like rival Pfizer, maintained its full-year sales forecast for the vaccine at $21 billion.

  • Moderna seeks US authorization for COVID vaccine in children under 6 Apr 28, 2022 06:49 PM IST

    Moderna seeks US authorization for COVID vaccine in children under 6

    Children under six are the only age group that has yet to gain access to a COVID-19 vaccine in the United States and in most countries.

  • Moderna says trial results suggest redesigned vaccines can better protect against variants Apr 20, 2022 09:21 AM IST

    Moderna says trial results suggest redesigned vaccines can better protect against variants

    The company’s findings, published in a paper without being evaluated by outside scientists, offer hope that the nation will have a better vaccine by the fall, when the coronavirus is considered likely to reemerge in force.

  • Who really needs a second COVID booster? Here’s what to know Mar 31, 2022 11:33 AM IST

    Who really needs a second COVID booster? Here’s what to know

    The Food and Drug Administration authorized extra Pfizer or Moderna shots for anyone 50 or older and for some younger people with severely weakened immune systems. It’s an effort to get ahead of a possible next coronavirus surge.

  • Moderna says its low-dose COVID shots work for kids under 6 Mar 24, 2022 11:31 AM IST

    Moderna says its low-dose COVID shots work for kids under 6

    Moderna said that in the coming weeks it would ask regulators in the US and Europe to authorize two small-dose shots for youngsters under 6. The company also is seeking to have larger doses cleared for older children and teens in the US.

  • Moderna seeks FDA authorization for second COVID booster for all adults Mar 18, 2022 11:01 AM IST

    Moderna seeks FDA authorization for second COVID booster for all adults

    Moderna, without specifically commenting on the effectiveness of a fourth shot, said its submission was partly based on data recently published in the United States and Israel following the emergence of the Omicron variant.

  • EU watchdog approves Moderna Covid jab for children six to 11 Feb 24, 2022 11:06 PM IST

    EU watchdog approves Moderna Covid jab for children six to 11

    The jab, developed by US-based pharmaceutical company Moderna, has already been approved for adults and children aged 12 and above.

  • Moderna, Pfizer Didn't Want Responsibility for Adverse Effects of Vaccines: Niti Aayog Member Feb 18, 2022 08:03 PM IST

    Moderna, Pfizer Didn't Want Responsibility for Adverse Effects of Vaccines: Niti Aayog Member

    Dr Paul was heading the initiative of negotiating with these three vaccine makers on behalf of the central government. Despite the demands, he said, the government tried to find more ways for these companies to bring the vaccines to India.

  • Moderna eyes COVID booster by August, not clear yet if Omicron-specific needed Feb 17, 2022 06:32 AM IST

    Moderna eyes COVID booster by August, not clear yet if Omicron-specific needed

    Last month Moderna began clinical trials for a booster dose specifically designed to target Omicron but initial results from studies in monkeys show the Omicron-specific shot may not offer stronger protection than a new dose of the existing vaccine.

  • US grants full approval to Moderna's COVID vaccine in adults Feb 01, 2022 07:41 AM IST

    US grants full approval to Moderna's COVID vaccine in adults

    Nearly 75 million people have already received Moderna's two-dose vaccine in the United States, according to data from the U.S. Centers for Disease Control and Prevention.

  • Moderna improves forecast for 2022 sales from COVID-19 vaccine Jan 10, 2022 07:03 PM IST

    Moderna improves forecast for 2022 sales from COVID-19 vaccine

    The company also said it was developing a booster vaccine candidate, called mRNA-1273.529, that targets the fast-spreading Omicron variant and expects it to advance into clinical trials in early 2022.

  • Moderna says booster dose of its COVID-19 vaccine appears protective vs Omicron Dec 20, 2021 03:49 PM IST

    Moderna says booster dose of its COVID-19 vaccine appears protective vs Omicron

    The vaccine maker said the decision to focus on the current vaccine, mRNA-1273, was driven in part by how quickly the recently discovered variant is spreading. The company still plans to develop a vaccine specifically to protect against Omicron, which it hopes to advance into clinical trials early next year.

  • Japan adds Moderna shot to COVID vaccine booster arsenal, joining Pfizer Dec 16, 2021 10:26 AM IST

    Japan adds Moderna shot to COVID vaccine booster arsenal, joining Pfizer

    The move followed a recommendation from health ministry experts on Wednesday that Moderna’s mRNA shot, used mostly at workplace inoculation sites to date, could be used as a third booster shot for those aged 18 or older.

  • Moderna Covid vaccine highly effective 5 months after second dose: Study Dec 02, 2021 01:58 PM IST

    Moderna Covid vaccine highly effective 5 months after second dose: Study

    The research, published in The Lancet Regional Health – Americas journal, evaluated the five-month effectiveness of the Moderna COVID-19 mRNA vaccine as part of an observational study.

  • Brain problems found in 1 percent of hospitalised COVID-19 patients; real-world data shows Moderna vaccine highly effective Dec 02, 2021 10:43 AM IST

    Brain problems found in 1 percent of hospitalised COVID-19 patients; real-world data shows Moderna vaccine highly effective

    A summary of some recent studies on COVID-19

  • Moderna chief predicts existing vaccines will struggle with Omicron Nov 30, 2021 12:01 PM IST

    Moderna chief predicts existing vaccines will struggle with Omicron

    Stéphane Bancel foresees ‘material drop’ in effectiveness of current jabs against new variant

  • US expands COVID boosters to all adults, final hurdle ahead Nov 19, 2021 07:14 PM IST

    US expands COVID boosters to all adults, final hurdle ahead

    Pfizer and Moderna announced the Food and Drug Administration’s decision after at least 10 states already had started offering boosters to all adults. The latest action simplifies what until now has been a confusing list of who’s eligible by allowing anyone 18 or older to choose either company’s booster six months after their last dose — regardless of which vaccine they had first.

  • Pfizer, BioNTech, Moderna making $1,000 profit every second: analysis Nov 16, 2021 12:19 PM IST

    Pfizer, BioNTech, Moderna making $1,000 profit every second: analysis

    The companies have sold the vast majority of their doses to rich countries, leaving low-income nations in the lurch, said the People's Vaccine Alliance (PVA), a coalition campaigning for wider access to COVID vaccines, which based its calculations on the firms' own earning reports.

Sections
ISO 27001 - BSI Assurance Mark